erythromycin has been researched along with Hypersensitivity, Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoshiba, K; Isono, K; Kondo, M; Kori, K; Nagai, A; Tagaya, E; Tamaoki, A | 1 |
1 other study(ies) available for erythromycin and Hypersensitivity, Type III
| Article | Year |
|---|---|
[Effects and action mechanisms of macrolides on IgG- immune complex lung injury models].
Topics: Animals; Anti-Bacterial Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Erythromycin; Immune Complex Diseases; Immunoglobulin G; Josamycin; Lung Diseases; Macrophages, Alveolar; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2001 |